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ABSTRACT 
 
 
INTRODUCTION 
 
Surgery, infection, injury and stress all these factors pose a catabolic state by 
the presence of an inflammation and thereby depletion of   conditionally essential  
nutrients leading to increase in the risk of  postoperative   complications and  
eventually   delay  the recovery and  enhance  the overall morbidity of the surgical 
patients. 
 
AIM 
The study aims to investigate the effect of Immunonutrients on patients  
undergoing Elective Major Gastrointestinal surgery  by assessment of changes in  
the clinical outcome in terms of postoperative complications compared to a  
normal  diet. 
 
MATERIALS AND  METHODOLOGY 
 
A prospective non randomnized study which included 50 patients who 
underwent major elective GI surgery for both benign and malignant diseases with 
IMN supplementation. The study group n=50 where administered 30 gms of IMN 
formula three times a day for 5 days preoperatively by oral route.The control group 
were given a normal diet during the study period.The preoperative variables 
measured were weight,BMI.The post operative variables are the primary outcomes 
of infectious complications such as SSI,UTI,pneumonia ,wound abscess and 
anastomotic leaks were recorded in the prescribed proforma.\ 
 
CONCLUSION: 
 The study outcome has proved a beneficial reduction of  infectious 
complications  and  substantial improvement  with the immunonutrient formula  
and it emphazies  the subset of malnourised patients are markedly benefitted . 
 
 
 
 \ 
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 INTRODUCTION 
 
Surgery, infection, injury  and stress all these factors pose a catabolic 
state by the presence of an inflammation and thereby depletion of   
conditionally essential  nutrients leading to increase in the risk of  
postoperative   complications and  eventually   delay  the recovery and  
enhance  the overall morbidity of the surgical patients. 
              Inspite  of  advancement  of modern surgical practices, minimal   
surgical trauma and newer generations of antibiotics and improved 
perioperative care in the recent years, the increase in postoperative infection 
rate is still of great concern. The role of nutrition in the recovery from 
trauma or surgical insult  has been researched  by clinicians since the period 
of Hippocrates. Poor nutritional diet  or deficiency of individual nutrients 
markedly alters the numerous  factors of wound healing. The  interaction of 
nutrition and wound healing is still not clearly deciphered. Efforts are  made 
to develop wound-specific nutritional interventions and the pharmacological  
use of specific nutrients as modulators . 
             The role of Immunonutrients as a supplemental nutrition in elective 
gastrointestinal surgical patients and modulating the inflammatory response 
and  improvement in postoperative outcome is to be evaluated . 
 
  
 
 
 
AIM 
          The study aims to investigate the effect of Immunonutrients on 
patients  undergoing Elective Major Gastrointestinal surgery  by assessment 
of changes in  the clinical outcome in terms of postoperative complications 
compared to a  normal  diet. 
 
 
 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
The “GUT ORIGIN OF HYPOTHESIS” mentions the leaky gut 
has a predominant role in the occurrence of  sepsis with the concept of 
bacterial migration in vivo and in vitro .The intestinal barrier  is of major 
importance as the distal small bowel and colon contain enormous 
concentration of bacteria. Under  extreme clinical conditions like surgery 
and stress the intestinal barrier function is impaired, resulting in the 
movement of bacteria and toxins to the systemic circulation .This process of 
bacteria and its products  moving across the intestinal mucosal barrier and 
with  a systemic spread  is known as bacterial translocation.     Enteral 
nutrition supplies the intestinal mucosa  and  maintains Gut associated  
lymphoid tissue and decreases the bacterial translocation to the portal vein. 
The integrity of the  mucosal barrier and  functioning immune system are  
prerequisites for adequate gut  function. The concept of gut barrier failure 
and bacterial translocation lead to the major impetus of initiation of early 
enteral feeding after injury. Enteral feeds maintain the  intestinal structural 
integrity by increasing the mucosal  mass, enhancing luminal epithelial cell 
proliferation ,maintaining villus height and stimulating the brush border 
enzymes.Enteral feeding preserves the intestinal barrier function better  than 
parenteral route. 
 Malnutrition and immune dysfunction are synergistic and most often 
occur in hospitalized patients. Gastrointestinal malignant  patients are more 
susceptible for malnutrition due to poor oral intake and cachexia. 
Immunonutition as a modality of intervention  dates back to 3000 years in 
ayurvedic medicine. Malnutrition has increased the infection rate from 0.1% 
in the well nourished to 18% in the malnourished. The organisms measles, 
tuberculosis and pneumocystitis carnii are more susceptible in immune 
compromised patients. Malnutrition has an impact on wound healing. 
Protein catabolism can result in a delay in wound healing. A 
hypoalbumineamic patient  experiences wound dehiscence ,with the 
albumin level  of  <2 gm/dl and protein supplementation can reverse this 
effect. 
 
ANATOMY OF INTESTINE 
Small Intestine: 
 The duodenum, jejunum, and ileum  are the constituents of small 
intestine. The duodenum is anatomically distinct, but the jejunum (proximal 
two fifths) and ileum (distal three fifths) have no true anatomic border 
between them  
 
 
  
The Duodenum  
 The duodenum hasfour parts: the first portion or the bulb, the second 
or descending portion, the third or transverse portion, and the fourth or 
ascending portion. The first portion begins at the pylorus and sweeps to the 
right; it is anchored by the hepatoduodenal ligament. The Blood is supplied  
from the supraduodenal & gastroduodenal arteries; both arise from  hepatic 
artery. 
 The second portion of the duodenum travels posteriorly and  is 
caudad to the level of  first lumbar vertebra. The arterial supply is from the 
celiac axis through the gastroduodenal artery to the anterosuperior and 
posterosuperior pancreaticoduodenal arteries and from the superior 
mesenteric artery (SMA) through the anteroinferior and posteroinferior 
pancreaticoduodenal arteries. 
Third portion begins as the duodenum sweeps to the left at the level 
L3 vertebra. It is associated with pancreas and superior mesenteric artery. 
 The fourth portion of the duodenum begins at the aorta, extends to the 
left, and passes ventral to the left psoas. It emerges into the peritoneum at 
the duodenojejunal flexure, which is fixed to the posterior abdominal wall at 
 the ligament of Treitz, Venous drainage from the duodenum is through the 
splenic, superior mesenteric, and portal veins. 
Jejunum and Ileum 
 The jejunum and ileum comprise of the  latter two parts of the small 
intestine (23). The jejunum origins at the duodenojejunal flexure. There is 
no clear line of division between jejunum and ileum (24).  
 The blood supply of the jejunum and ileum derives from the SMA, 
which has an extensive anastomotic network near the mesenteric border of 
the bowel called the marginal artery. 
 
         The jejunum tends to have a single marginal artery from which arise 
long, relatively straight branches of the vasa recta. This pattern gradually 
blends into arcades that travel close to the mesenteric edge of the bowel and 
give rise to short branches in the ileum.  
  The intestine tends to become thinner and paler distally, along with a 
decrease in diameter. Lymphatic tissues to the small intestine, called Peyer's 
patches are most numerous in the distal ileum, whereas plicae circulares are 
more prominent in the proximal jejunum.  
 The vascular supply to the small intestine arises from SMA. The 
arterial branches derived from SMA pass through the two layers of the 
mesentery into the gut at the mesenteric margin of the small bowel.  
 In the jejunum, the arcades are comprised of long vasa recta (3 to 5 
cm), whereas in the distal ileum the arcades are elongated and the vasa recta 
are relatively short. Venous drainage from the intestine parallels the arterial 
supply, with the superior mesenteric vein being the major venous collecting 
system; it also lies within the mesentery to the right of the SMA. 
Innervation to the small intestine is through the autonomic nervous 
system and includes sympathetic, parasympathetic, and enteric divisions. 
Sympathetic fibers arising from thoracic segments of the spinal cord 
synapse in the celiac ganglion. Parasympathetic fibers arise from the vagus 
nerve and synapse in the submucosal (Meissner's) and myenteric 
(Auerbach's) plexus. 
 
 The Large Intestine 
The large intestine originates from both the midgut and the hindgut. 
The colon is approximately 150 cm long, and its greatest caliber is 7.5 cm at 
the cecum, from where it gradually diminishes to 2.5 cm at the rectosigmoid. 
 The longitudinal muscle layer is concentrated to form three linear 
bands that are equidistant from each other and make up the taeniae coli. 
These shorter taeniae cause the circular muscle coat to be puckered and 
thrown into haustral sacculations because the length of the taeniae is less 
than that of the bowel wall.  
 The taeniae extend from the tip of the cecum to the rectosigmoid and 
are approximately 6 mm wide. Most of the colon, other than the appendix 
and cecum, is peppered with peritoneum-covered adipose pieces known as 
appendices epiploicae.  
CECUM  
 The cecum is the commencement of the large intestine and just above 
the ileocecal valve. Its average axial diameter is approximately 6 cm, with a 
breadth  of about 7.5 cm. Anteriorly, cecum is in contact with the anterior 
abdominal wall but may have greater omentum or coils of small intestine 
 overlying it. The cecum is mobile and has a complete covering of 
peritoneum, although this may be absent at the superior part. 
ASCENDING COLON  
 The ascending colon is narrower than the cecum at its origin and is 
about 15 cm long. It then turns down, forward, and to the left, forming the 
hepatic flexure. The ascending colon is covered on all sides except its 
posterior surface. It is not uncommon for it to be completely covered with 
peritoneum and to contain a narrow mesocolon. The hepatic flexure has a 
vertical mobility of 2.5 to 7.5 cm with respiration. 
 
TRANSVERSE COLON  
 The transverse colon begins at the hepatic flexure and passes across 
the abdomen into the left upper quadrant, where it curves acutely onto itself, 
down and backward, to form the splenic flexure. It is about 50 cm long, and 
in its course across the abdomen, it forms an arch with its concavity facing 
backward and up. The transverse colon is almost completely covered with 
peritoneum between the head of the pancreas and the splenic flexure. 
  The transverse colon merges into the descending colon at the splenic 
flexure.  
 This may be so acute that the distal transverse colon lies anterior to 
the descending colon. The splenic flexure is connected to the diaphragm by 
the phrenicocolic ligament, at the level of the 10th and 11th ribs. 
DESCENDING COLON  
 Descending colon is 25 cm, long and starts at the splenic flexure up  
to the pelvic brim. It is covered by peritoneum over its anterior surface and 
side. On its anterior aspect, it is related to the coils of the small intestine, 
and in its lower portion, it is related to the anterior abdominal wall. 
SIGMOID COLON  
Sigmoid colon begins at the pelvic brim and forms a loop of about 40 
cm that lies within the pelvis. It becomes continuous with the rectum at the 
level of S3 vertebra and is marked by lower end of the sigmoid mesocolon. 
ARTERIAL SUPPLY  
 SMA supplies the colon to a level just short of the splenic flexure. 
IMA supplies the large intestine upto the mucous membrane of the upper 
third of the anal canal. The following branches are responsible for supplying 
the colon: 
 1. The ileocolic artery branches early from the superior mesenteric trunk. 
The artery then divides into anterior and posterior cecal arteries to 
supply  cecum.  
2. The right colic artery has its origin to the right  of the root of  SMA. 
At left side of colon, it branches into a descending branch, which 
anastomoses with the colic branch of the ileocolic artery, and an 
ascending branch, where it anastomoses with a branch of middle colic 
artery. 
 
 
 
 Less complex arterial arcades 
 Longer  Vasa Recta 
 More plicae circulares, thicker, more highly folded 
 No fat in mesentery  
  
 
 
 
vascular anatomy of large intestine 
3. The middle colic artery is the most proximal branch of the SMA. It 
divides into right and left branch at the transverse colon. The right 
branch anastomoses with the ascending branch of the right colic 
artery, whereas the left branch anastomoses with a branch of the left 
colic artery.Inferior mesenteric artery arises opposite the L3 vertebra 
from the front of the aorta. The following branches supply the left 
side of the colon: 
  
The first branch is the left colic artery. It then leaves as  the upper 
branch, and  lower branch. Both branches further divide into branches that 
anastomose with the left branch of middle colic artery. 
 Sigmoid arteries are three or four branches that arise from a common 
origin at the inferior mesenteric artery below the left colic artery. They pass 
forward in the sigmoid mesocolon and supply the sigmoid colon. 
 The marginal artery is the name given to a single arterial trunk made 
up of anastomoses around the concave border of the large intestine from the 
ileocecal junction to the rectosigmoid junction. The marginal artery is 
therefore made up of branches of both the superior and inferior mesenteric 
arteries. 
VENOUS DRAINAGE  
  Veins from the right side of the colon flow into the superior 
mesenteric vein (SMV), which drains the midgut. Veins from the left side of 
the colon flow into the inferior mesenteric vein (IMV), which drains the 
hindgut. 
 
 
 PHYSIOLOGY OF GASTROINTESTINAL SYSTEM: 
 The mouth is the entry to the digestive system and  food is physically 
broken and  deglutition of the food is facilitated  by moistening and 
initiation in  the  breakdown of  carbohydrates and fats by the enzymes 
ptyalin and lingual lipase. It  contains  antimicrobial factors   like IgA which 
neutralizes the bacteria in the  food. PH of saliva is 6-8. Total salivary 
secretion is 1.5 litre. Saliva has the second highest concentration of 
potassium next to colon. 
Stomach: 
  It  contains numerous rugae and folds. The muscular contractions 
mixes and churns the food with the enzymes to form chyme. The parietal 
cells secrete HCL and intrinsic factor which breaks the particles of 
food ,initiates protein digestion by activating pepsinogen to pepsin. The 
absorption of vitamin B12 is depended on the  Intrinsic factor and it occurs 
in the distal ileum. Gastrectomy patients  develop pernicious anemia  due to 
the lack of IF. Gastric juice amounts to 2litres .PH is 1-2. The surface area is 
0.053 m2 small compared to the small intestine . Gastrin is the principal 
hormone 
 
 SMALL INTESTINE: 
It is made up of four main layers-muosa, submucosa, muscularis 
propria and serosa. The inner layer is the mucosa and it is composed of the 
epithelium ,lamina propria and muscularis mucosae. The mucosa functions  
as  a site of absorption of nutrients and water from the intestinal lumen. The 
submucosa is the strength layer of the bowel wall and is composed of the 
connective tissue. When completing a bowel anastomosis it is important to 
include bites through this layer of tissue to ensure integrity of the 
anastomosis. 
 
  The maximum site of absorption are due to the numerous increased 
villi and micro villi which increase the surface area to 200 m2. Villi are 
finger like projections of the mucosa and are longest in the duodenum where 
most of the absorption occurs and shortest in the distal ileum. The 
carbohydrates are  hydrolyzed by the enzymes in the brush border. Succus 
entericus  are the small intestinal secretions which amounts to 2litres and the 
majority portion is water 98.5% and solids 1.5% .Paneth cells activate the 
enterokinase   and which further releases the pancreatic zymogen granules 
for digestion. PH is 8-9. The acidic nature of the chyme is neutralized by the 
alkaline secretions . 
 
 
 
 LARGE INTESTINE: 
 It contains the maximum number of bacteria in the  entire GI system. 
 
The amount of water excreted in the faeces is 150 ml. 
MIGRATORY MOTOR COMPLEX: 
Periodic and intense electrical activity are seen in the fasting  stomach 
and intestine that lasts for 3-6 minutes and spreads from the stomach to the 
ileum. It is cyclical and repeated every 90 minutes  and migrate at  the rate 
of 5cm/minute. It clears the stomach and small intestine of luminal contents  
in preparation for the next meal. Gastric, pancreatic and bile flow increase 
during MMC. Food ingestion  inhibits the MMC. 
 
  
TYPES of contractions : 
Segmental: 
 The pacemaker  are  the  interstitial cells of cajal  which are  
stellate mesenchymal cells that are present between the inner circular and 
outer longitudinal layer and initiates the frequency of the 
contractions.Pacemaker cells are absent in the esophagus and proximal 
portion of stomach. The cajal cells produce basal electrical rhythm which is 
the spontaneous fluctuation of the membrane potential between -65 and -
45mv. The BER rarely causes muscle  contraction but the superimposed 
spike potential increase the muscle tension. The rates of  BER in the  
stomach-4/mt and duodenum is 16/mt. The segmental contractions moves 
the chyme to and fro and increases the  exposure to  mucosal surface and  
helps in mixing of the chyme with  digestive juices. 
 
 
 HAUSTRATION: 
  They are mixing movements of  the colon due to the circular muscle 
action and during the  fasting  period the colonic motility is minimal . The 
haustrations are formed due to the shorter length of the taenia coli which are 
the bands of the longitudinal muscle in comparison to the length of the 
intestine.  They are slow segmenting , uncoordinated movements that occur 
approximately every 25 minutes .Fat component of the meal stimulates the 
colonic contraction.Protein ingestion inhibits colonic motility. Decending 
colon has the  maximum postprandial increase in contraction. 
TRANSIT TIME : 
The time taken for food to travel from the pharynx to esophagus is 6 
seconds due to gravity and peristalsis. Water empties from the stomach in 
12 mts.Gastric  emptying time of the meal is 4 hours. The carbohydrate 
portion empties first followed by proteins and fat is the last. Chyme takes                 
3-4 hours to reach the ileum. Large intestine transit time is 2-4 days and 
with the increase in dietary fibre content ,it is reduced. 
 
 
 
 
 CARBOHYDRATE ABSORPTION:  
The major portion of the diet contain starches 
(polysaccharides) ,sucrose and a  small amount of lactose. Gycogen is 
animal starch but the  80%  of food contains  amylopectin and amylose. The 
average daily intake of carbohydrate is in the form of starch  64%,sucrose 
26% and fructose 3%. Starch is  digested by ptyalin from the saliva  and this 
enzyme is inhibited by gastric juice. And cleaves the 1,4 linkage .Chyme  is 
acted upon by the pancreatic amylase and it spares the 1,6 linkage 
hydrolization and the end products are Maltose, Maltotriose and limit 
dextrins. The three oligosaccharides are acted by the intestinal 
disaccharadise present in the microvilli of the ileum and degraded to 
oligosaccharides.Glucose is the primary energy source providing 30-40% of 
calories in atypical diet.The brain and redblood cells rely almost exclusively 
on a supply of glucose to function. Each gram of enteral carbohydrate 
provides 4kcal of energy.During fed states , hypoglycaemia leads to insulin 
secretion which promotes the glycogen synthesis. About 12hours of 
glycogen is available in the liver andd skeletal muscles, which provides a 
steady supply of glucose in between meals. In times of  starvation and 
stress ,depleted glycogen stores cause the release of glucagons, which 
promotes the hepatic gluconeogenesis from aminoacids.If dietary 
 carbohydrates are not resumed ,glucagons promotes ketone body formation 
from lipids ,which the brain can utilize. A minimum intake of 400 calories  
of carbohydrate per day minimizes protein breakdown, which is 
administered in maintenance IV fluids during Nil per oral.  
 
The glucose and galactose are absorbed  by the Na+symport ,contrarily the 
fructose is absorbed by the facilitated diffusion. Insulin has no effect on the 
intestinal absorption of sugars. The maximum rate of glucose absorption 
from the intestine is 120 gm/hour. 
 
LIPID DIGESTION: 
Fatty acids are the functional units of lipid metabolism. Fats are ingested as 
triglycerides ,phospholipids ,cholesterol and cholesterol esters. Triglycerides 
are the most abundant .Pancreatic fluid provides enzymes integral in the 
digestive process of fat. Fat digestion also requires bile from the liver for 
emulsification, which is the process by which large fat globules are broken 
 down into smaller sizes that are easier targets for water soluble enzymes. 
 
The dietary fat is composed of large fat globules of triglygerides and is 
emulsified by the detergent action of bile salts into a suspension of small fat 
droplets. This lipid emulsification prevents the fat droplets from coalaescing  
and thereby increase the surface area for action by the pancreatic lipases. 
Furthur the lipase hydrolyzes the triglycerides into monoglycerides and free 
fattyacid. These water insoluble products are carried into the water soluble 
micelles and are presented to the intestinal epithelial cells. The monogl 
 yceride and fatty acid leaves the micelle and diffuses passively through the 
lipid bilayer of the luminal membrane. The resynthesis of the triglyceride 
occurs inside the epithelial cell .The TGL aggregates are coated with a layer 
of lipoprotein to form water soluble chylomicrons which are extruded 
through the basalmembrane of the cells by exocytosis. Chylomicrons are 
unable to cross the basement  membrane of capillaries and instead enter the 
lymph vessels. 
 
PROTEIN DIGESTION:  
 
 
There are three main sources of protein : dietary, endogenous 
secretions and desquamated cells .Protein digestion begins in the stomach 
via pepsin and proceeds in the small intestine. Pancreatic proteases enter the 
duodenum in an inactive state as proenzymes. The proenzymes are activated 
by the brush border enzymes. The two main classes of enzymes are 
endopeptidase and exopeptidase. The most important is trypsinogen  is 
 converted to the active enzyme trypsin by enterokinase.Once active it 
converts the other proenzymes into their active forms. Proteases  break 
down the proteins into short oligopeptides and aminoacids. The brush 
border enzymes peptidases further hydrolyze the oligopeptides into free 
aminoacids, dipeptides, and tripeptides which can all be absorbed by 
enterocytes. Dipeptides and tripeptides are easily absorbed by the enterocyte 
because they are transported via a transmembrane H+ gradient.Aminoacids 
require an active Na+ transport. The majority of protein absorption takes 
place in the jejunum. 
 
INFLAMMATION: 
It is classified into acute and chronic. It is a  series of molecular and 
cellular responses to eliminate foreign antigens  or damaged (necrotic) cells 
and promote repair of damaged tissues. A protective response to initiate 
repair process and return the damaged tissue to useful function. In the 
absence of inflammation  wounds and infection will never heal. The 
cardinal signs of acute inflammation was coined by CELSUS and are 
Rubor-redness is due to vasodilatation of small blood vessels ,Tumour-
swelling (exudation of fluid),color-heat (increased blood flow due to 
vasodilation), DOLOR-Pain(stretching of tissue due to edema). The fifth 
 clinical sign was added by Rudolf Virchow as FUNCTIO LAESIO-loss of 
function. 
PATHOPHYSIOLOGY OF ACUTE INFLAMMATION: 
It has three major steps 1) vasodilation-alteration in vascular caliber 
that leads to increase in blood flow, earliest manifestation 2)  vascular 
permeability-leads to escape of protein rich fluid (exudate) and leucocytes 
into extravascular spaces. Intravascular osmotic pressure reduces to 
exudation of proteins  and osmotic pressure of interstitial fluid is increase 
and shift of fluid in the interstitial compartment. Fluid loss  leads to 
increased viscosity of blood and stasis. 3)Extravasation of the leucocytes 
from the capillary circulation , and movement towards the foci   of injury 
and their stimulation to eliminate the microbial organisms by-chemotaxis 
and phagocytosis. As stasis develops leucocytes accumulate along the 
endothelium known as margination. Next process is tumbling   of leucocytes   
along the endothelium and finally adhesion of the leucocytes to the 
endothelium and pavementing. Leucocyte diapedesis is the process of 
transmigration across the endothelium  and is regulated by the binding of 
adhesion factors–Selectins, Integrins and mucin like glycoproteins. 
Diapedes is predominantly occurs in the venules the exception in the lungs 
where it occurs in the capillaries. By chemotaxis  the leucocytes migrate to 
 the site of injury and the chemoattractants are bacterial products and 
C5a,IL-8, LT4.Prolonged inflammation leads to destruction and healing of 
the tissue and diabetes, obesity, rheumatoid arthritis etc are examples. 
Chronic inflammation damages the organs and tissues ,the acute 
inflammation is an adaptive response.  
METABOLIC RESPONSE TO TRAUMA: 
Surgical  insult   activates a complex  cascade  of metabolic host 
responses  to meet the bodys  homeostasis. The initial period is 
characterized by the protein breakdown ,increased utility of oxygen 
& ,insulin resistance . The changes that ensue are  hyperglycaemia  due to 
increased hepatic glucose production and skeletal muscle  insulin resistance. 
There is a marked negative nitrogen balance due to the skeletalmuscle 
metabolism which leads to wasting of the lean body mass. Glutamine is the 
preferred energy source of enterocytes and immune cells and the antioxidant 
glutathione.  Acute phase proteins and immune cells are produced in the  
liver at the expense of albumin. A redistribution of macronutrients from 
labile reserve(skeletal muscle and adipose tissue ) to more active tissues for 
host defense, visceral protein synthesis and heat production. Injury is 
associated with a pronounced neuroendocrine response characterized by 
increased secretion of stress hormones as adrenaline and cortisol and also by 
 increased release of GH , ADH etc. Cortisol is the most important hormone 
with its widespread effects on glucose, aminoacid and fatty acid metabolism. 
There is no evidence to date that hormonl treatment can improve the 
outcome after major injury. 
  
 
IMMUNE SYSTEM: 
 It is divided into the innate and acquired/adaptive immune responses. The  
fundamental function of the immune system is to combat  against the 
infection and other foreign proteins ( antigens) by  its recognition of  self 
antigens. If this mechanism fails it leads to autoimmune diseases. 
  
 INNATE: 
They are the first line of defense and are not specific to a particular 
pathogen and its specific elements are the epithelial barriers ,immune cells 
{neutrophils ,macrophages,dendritic cells and natural killer cells}.  The 
evolutionary history suggests that the stimulation of NFkB is the  main 
signaling pathway in innate immunity. It is   activated quickly in  response 
to invaders. The skin and epithelial lining of the lung and gut provide a 
 physical barrier from the outside world. Tight junctions between the 
neighbouring cells prevent early penetration by pathogen. The slimy 
mucous  is primarily made of mucin and mucoproteins and  protects against  
the pathogens adhering to the epithelium. The mucus layer consists of 
microbicidal substances that engulf and kill the pathogens. The most 
abundant antimicrobial peptides  are defensins.  
 
 
They are   amino acids with a broad spectrum of antimicrobial activity 
including the ability to kill and inactivate  the gram negative bacteria  ,gram 
positive bacteria ,fungi ,parasites and also HIV. The innate mechanism  
depends  on the  identification of specific types of molecules that  are  
common pathogens but are  absent in the host . 
  
These  molecules are known as pathogen associated molecular patterns 
(PAMP) or microorganism associated molecular patterns(MAMP) and  
activate  two types of responses –inflammatory and phagocytosis, both of 
 these  responses occur rapidly even if the host has  been never previously  
sensitized. The   known examples of PAMPs are lipopolysaccharides (LPS)  
in gramnegative bacteria ,lipoteichoic acid in grampositive bacteria and 
double stranded RNA viruses. Pathogen associated molecules occur on the 
microbe surface in repeatitive sequences. The  molecules are recognized by  
the dedicated receptors in the  host known as pattern recognition receptors  
and are  functionally divided into endocytic receptors  which causes  
internalization and phagocytosis of microbes.  
 The signaling receptors activate the cellular signaling pathways and  induce 
the expression of a multitude  of immune responses. These include soluble 
proteins in the  blood , as the complement system and the signaling 
receptors - membrane bound (toll like receptor family) and the G-protein 
coupled receptors. The toll like receptors   functions in two aspects to 
initiate the phagocytosis and activates  the progression of gene expression in 
the host for stimulating the innate response. 
COMPLEMENT SYSTEM: 
Complement system has 20 soluble proteins that are primarily  
produced  in the liver, and circulates in the extracellular fluid and blood. 
They are  inactive  until they are stimulated  by infection. Being a part of the 
innate immune system does not require prior immunization for activation. It  
 originally was identified by   their ability to enhance and support the action 
of antibodies. It is rapidly activated in a nonspecific manner in one the  three  
pathways –Classical, mannan-binding lectin and alternate pathway. In the 
classical pathway, it is activated by an IgG or IgM antibody –antigen 
complex.The alternate pathway does not rely  on the antigen-antibody 
complex,but it is directly stimulated by bacterial cell wall components.The 
Mannan binding pathway is similar  to the classical except that it is initiated 
by a cascade  by the liver producing mannan lectin when bound to a 
pathogen surface.C3 is the pivotal component .Deficiency of c3 are 
subjected to repetitive bacterial infections. The   initial complements and C3 
are  proenzymes which are activated  in a step wise manner by  proteolytic 
cleavage . A cascade  ensues in the series  and the  next complement is 
generated as a serine protease. All  the reactions  occur on the surface of the 
pathogen. Activation of the complement cascade results in the formation of 
products that act to kill the  microbes,attract the neutrophils by chemotactic 
action and stimulate both phagocytoses and bacterial killing through 
opsonization of bacteria and neutrophil degradation. 
TOLL LIKE RECEPTORS: 
 Humans have 10 toll like receptor, stimulate the expression of 
molecules  of  both innate and inflammatory  responses and adaptive 
 immune response. The  receptors are host  cell surface receptors  responsible 
for inducing the  gene expression in response to  microbes .TLR are 
numerous on the surface of  neutrophils and macrophages and on the  
epithelial lining of the respiratory tract and GIT .   Phagocytic cells  destroy 
the pathogens. The tissue macrophages reside   abundantly in areas where 
infection are most susceptible like  the lungs and gut.  They are   present  
abundantly in the  connective tissues ,liverand spleen, as kupffer cells and 
act primarily as the  frontline defense of the microbes . The neutrophils are  
absent  in the normal healthy tissue  but are   abundant in the blood .It is  
swiftly recruited to the  site of insult by the macrophages and peptides  
released by the pathogens. Macrophages & neutrophils have a plethora  of 
cell surface receptors that recognizes & engulfs the  pathogen. The 
pathogens are phagocytosed ,the macrophage and neutrophil releases  
enzymes to kill it eventually . The phagosome is fuse d with lysosomes 
which consists of  acid hydrolases & lysozymes that disintegrate  the 
bacterial cell wall  protein. The  phagocytes integrates the NADPH oxidase 
complex on the membrane and catalyzes the formation of  toxic compounds 
like superoxide  radical, hydroxyl, hypochlorite, H2O2. Macrophages  
continue to survey the tissues  whereas the neutrophils  are dead. The dead 
neutrophils are a major part of pus that is  found  in active wound infection 
sites. The  Greenish hue  of the pus is due to the presence of neutrophils and 
 its  copper containing myeloperoxidase enzyme. The activated macrophages 
recruit  the other phagocytic cells to the site of injury. Pathogen invasion of 
tissue  inevitably  elicits an inflammatory response. Response per se is 
characterized by    pain, redness, heat, swelling  due to changes in the local 
blood  vessels. Inflammatory  responses  are  initiated by a number of 
signaling   molecules.  The action of TLR  leads to the production of both 
lipid signaling  prostaglandins and peptides like cytokines ,most of the 
cytokines  produced by activated macrophages  are chemokines. The 
Chemokines recruit the neutrophils to the site of infection, and others attract 
monocytes and DC. DC picks up the antigen from the invading pathogen 
and carries them to the lymph node and are   presented to the  lymphocytes 
to channelize  the  adaptive immune system. Other cytokines trigger fever 
like IL 1 and helps the immune system to combat  the infections, as most  of 
them are  viral and bacterial pathogens which  grow at low temperatures.The 
immune system functions  more efficiently at high temperature. The 
proinflammatory signaling  molecules stimulates the endothelial cells to 
express the proteins that trigger blood coagulation in  the small blood  
vessels , and  inturn the occlusion  helps to prevent   the organisms from 
entering the circulation and limiting its spread to the  other   parts of the 
body. 
 
 ADAPTIVE IMMUNE SYSTEM: 
 The role  of adaptive immune response is to destruct  the pathogens 
and are  more  specific in the  production of  B,T Lymphocytes and the 
response occurs  in days to weeks .The responses are destructive ,it is 
crucial that the  foreign cells are identified and host cells are spared.  It 
consists of the humoral (extracellular microbes) and cell mediated immunity 
{intracellular microbes } 
Activation of a B cell in the humoral immune response. 
 The  protein antigens require activated helper T cells to initiate  a 
humoral response. A macrophage  or a dendritic cell can activate the helper 
T cell, which in turn activates the B cell to lead  to antibody-secreting 
plasma cells 
 
  The antigen  presenting cell engulfs and destroys the  pathogen,  
presents the antigen  fragment  complexed with a class II MHC 
molecule. The  helper T cell    recognizes  the complex  with the aid 
of cytokines ..  
 
 
 The  B cell  receptors for the same epitope internalizes the antigen , It 
expresses the  antigen fragment on the cell surface as a complex with 
the  MHC  class 11 molecule .An activated helper T cell bears the 
receptor specific for the displayed fragment and  binds to the B 
cell .With the  help of cytokines from the T cell, activates the B cell. 
  The activated B cell differentiates into memory B cells and antibody – 
Secerting plasma cells. The secreted antibodies are specific for the same 
 antigen that initiated the response . The T lymphocytes of the adaptive 
immune system have evolved to provide a more competent  means of 
defense   and  protection against subsequent re-infection with the same 
pathogen. There is  a delay of 4-7 days occurs  before the  response takes 
effect , and the innate  system has a definitive role in limiting the infection 
during this period. The  stimulation  of adaptive immune response starts 
when a pathogen is engulfed by an  immature DC in the infected tissue. The 
specialized phagocytic cells resides  in most tissues and are  comparatively 
of a  longer life span. DC  are derived from  the same Bone Marrow  
precursors as  macrophages and shifts  from the BM to the peripheral tissues 
to localize  for the  pathogens. Inevitably all tissue DC migrate  through the 
lymphsystem  to the regional lymph node and interact with naïve  
lymphocytes .If the DC fail to be activated ,they induce tolerance to the self 
antigen . The immature DC possess  receptors on its surface that recognizes 
the  pathogens such as bacterial cell wall p roteoglycans. Immature  DC  
takes up  extracellular material including any virus or bacteria that may be 
present by the receptor independent mechanism of   macropinocytosis. The 
function of Dc is solely not the  destruction of the pathogen but to sensitize 
the  peripheral lymphoid stuctures and present  to the T 
lymphocytes . .Highly effective APC secrete cytokines and activates the T 
lymphocytes  that regulate  both the innate and adaptive  immune response. 
 Tcells develop from the thymus and B cells develop in the BM in adults or 
the liver in the fetus. Inspite of  their different origin both T & B cells arise  
from the same pluripotent haemopoetic stem cells and give rise to  
leucocytes   .Primary lymphoid organs are the thymus and haemopoeitic 
tissue in the BM. Most lymphocytes die in the central lymphoid organs 
immediately after their development  without  ever functioning  and the 
others mature and migrate via the blood to the peripheral   lymphoid organs , 
GIT and respiratory tract epithelium.  Peripheral lymphoid organs is the site 
where  T& B cells react with foreign antigens.Both are  instigated by 
antigens to proliferate and sustain  into effector cells. Effector B cells  are 
the Antibody mediated immunity which induce the plasma cells to generate 
the  immunoglobins.There are two main classes of T cells –Cytotoxic and 
Helper T  cells. Cytotoxic T cells kills the infected cells  and the latter 
activates the macrophages, B cells and cytotoxic cells..B cells  secrete 
antibodies that are transported and are distributed in  the systemic 
circulation, where as T cells too are distributed to distant sites but  its action 
is confined only  on the neighbouring  cells.  
   
 
 An antigen – presenting cell (APC) encounters and  ingests 
microorganism. Antigen fragments (shorts peptides)from the 
microorganism combine internally with MHC molecules and  is 
presented on the surface of the APC 
 A helper T (TH) cell receptor binds to the complex, stimulating the 
APC to secrete interieukin-1 
  The interieukin-1 stimulates the helper T cell to produce interleukin-
2, which then stimulates the helper T cells to form  a clonal of cells.  
 Clonal cells in turn produce cytokines stimulating cells of both 
immune systems. 
 
 
 
 
 
 IMMUNOPHYSIOLOGY OF THE GUT: 
The large numbers of microorganisms that inhabit mammalian body 
surfaces  have a highly coevolved relationship with the immune system. 
Although many of these microbes carry out functions that are critical for 
host  physiology, they nevertheless pose the threat of breach with ensuin 
pathologies. The mammalian immune system plays an essential role in 
maintaining homeostasis with resident microbial communities, thus 
ensuring that the mutualistic nature of the host-microbial relationship is 
maintained.   The  important function of the intestinal  immune system is to 
control the exposure of  bacteria to host tissues and thereby reducing the 
pathologic  outcomes. This occurs at two levels – 
 
 
 
  minimizing the direct contact between the intestinal bacteria and the 
epithelial cell surface by stratification. 
 To confining the  intestinal bacterium to the intestine and limiting the 
exposure to the systemic compartment by compartmentalization. 
 
 
 
 
 STRATIFICATION:  
Intestinal epithelial goblet  cells  secret mucin glycoprotein  that form 
a thick viscous coat to the cell surface. In the colon there are 2 distinct  
mucus layers, the outer layer consists of large number of bacteria, the inner 
layer is resistant to penetration. small intestine  has no 2 mucus layers but 
Reg 111gamma is an antibacterial lectin expressed by the epithelial cells 
and limits the microbe penetration. It also depends on the IgA which 
specific for the intestinal bacterium is produced with the help of Dendritic 
cells. These bacterial laden DC interact with  T,B cells of Peyers 
Patches ,inducing B cells to produce IgA and transcytosed  across the 
epithelium and deposited on the apical surface. GIT with a surface area of 
300-400m2 next only to respiratory tract  is the largest  surface connecting 
to the outer world. in  The   majority portion of the body’s immune system  
about 60- 70% is localized to the GI lamina propria and mesenteric   lymph 
nodes ,collectively referred as GALT.GI epithelial cells are replaced every 
3-4days ,it  adds to 55 million cells are renewed every minute. 
Intestinal immune system: 
It has two components-acquired or adaptive immune system-consists 
of peyers  patches, IgA  plasmocytes  and lamina propria lymphocytes 
Effector pathway of intestinal epithelial cells, macrophages, eosinophils  
 and dendritic cells. Peyers patches are collections of lymphoid follicle 
located in the terminal ileum, appendix and colon. 
CYTOKINES: 
They are small proteins secreted by systemic immune cells 
macrophages, monocytes, lymphocytes and are crucial mediators in cell 
mediated immunity and inflammatory response. In healthy humans they are 
produced at low levels in plasma and function in a endocrine, paracrine or 
autocrine manner. They activate the intracellular signaling pathway NFkB 
gene expression which plays the cetral role in inflammatory cascade. They 
are not antigen specific and their effect can be inhibitory and stimulatory. 
The dominant proinflammatory cytokines are TNF,IL-1b,IL-6,IL-8,IL-
12and IFN-gamma and the anti-inflammatory are IL-4,IL-10 and IL-13.The 
t-1/2 of circulating unbound cytokines is <5minutes to a few hours.TNF is 
the best described proinflammatory cytokine and is mainly produced by 
macrophages ,monocytes ,Tcells ,endothelial cells,fibroblasts and adipose 
tissue.It is the earliest cytokine secreted after trauma with a t-1/2 <20 
minutes .It acts through its receptors TNF1 and TNF2.  
Cytokines post elective surgey- 
The acute phase response is related to the surgery related trauma or 
severity of the surgical related procedures. All the mediators of 
 inflammation peak post injury at about day 1 and 2 and return to baseline 
values by POD 6. Persistent pain, stress or a second insult will change the 
pattern.IL-1,IL6 & TNF are pluripotent cytokine which are intimately 
associated with the infection and inflammatory response.IL-6 can be 
produced by not only monocytes but also by  endothelial cells and intestinal 
epithelial cells.The cellular and physiologic effects are diverse and induce 
fever, Tcell proliferation, promotion of differentiation of nerves  and 
induction of synthesis of acute phase response in the 
hepatocytes.Circulatory  concentrations of IL-6 dramatically increases after 
tissue injury like elective surgery, trauma & burns. The degree to which IL 6 
is elevated correlates with the risk of post injury complications. 
OXIDATIVE RADICALS: 
They are a chemical species that have a single unpaired electron in 
the outermost  orbit. Most of these are  reduced reactive oxygen forms that 
are produced by the  unavoidable  byproducts  of mitochondrial  respiration. 
Reactive oxygen species are hydrogen peroxide, superoxide anionO2, and 
hydroxyl radical(OH).They are highly toxic and damage the cell membrane 
and nucleic acids and initiate autocatalytic reactions to propagate the chain 
of damage. The reduction –oxidation  reaction during normal metabolic 
process are the rapid burst of superoxide  which occurs in activated 
 neutrophils during the process of inflammation with the help of NADPH 
oxidase. Transitional metals like cu and iron catalyze the free radical 
formation. NO generated in the endothelium and macrophages can act as a 
free radical. Cell injury is accomplished by lipid peroxidation and 
subsequent damage of the cellular and mitochondrial membrane, oxidative 
modification and degradation of intracellular proteins and DNA strand 
breakage. 
ANTIOXIDANTS: 
 It is defined as any molecule capable of  deactivating the free 
radicals before they attack the host cells .Humans have highly integrated  
antioxidant systems both enzymatic and non enzymatic which is symbiotic 
and protects the cells and organs  against free radical injury .They are 
classified as endogenous and exogenous .The most efficient are enzymatic 
1)glutathione peroxidase 2) catalase  3)superoxide dismutase. The 
nonenzymatic are vitamin C, E, Thiol, melatonin, carotenoids and natural 
flavenoids. However surgery, infection and inflammation promote oxidative 
stress and endogenous antioxidants may not be sufficient and dietary 
antioxidants are required to optimize the function. 
 
 
 MECHANISM OF NONENZYMATIC ANTIOXIDANTS 
Gultathione :Y-Glutamyl - Cysteinyl-Glyaine 
 
 The reduced form (GSH)is a strong antioxidant that protects cells against 
damage caused by free radicals and it recycles vitamin C and E . 
 Serves as substrate for cof actor in GSH - linked enzymes 
        1.Gultathione transfaminase (GST) 
        2.Gultathione peroxidase (GPx)  
 The oxidised form (GSSG) is catalysed by Glutathiane reductase 
(GSR)back    to GSH using NADPH as reductant  
 Glutathione is utilized by the white blood cells as an  energy source used  
for lymphoproliferation glutathione  helps to increase the resistance to 
bacterial and viral infections)  
 Glutathione is a natural purifier (high concentrations are found in the 
liver for detox purposes) 
  
VITAMIN C: 
It is championed by Linus pauling in 1928 as an antiviral and 
anticancer nutrient .It functions as a booster to immune system. It is 
essential for collagen, carnitine and neurotransmitter synthesis. Humans 
cannot synthesize due to lack of an enzyme gulonolactone oxidase  and is 
essential to be made available in the diet. History of scurvy occurred in sea 
voyagers and sailors and the British naval physician Lind documented citrus 
fruits cured the disease. Main sources are grapefruits, watermelon, papaya, 
citrus fruits, broccoli etc.US RDA  is 40-60mg/day.  
  
SELENIUM: 
 It is an essential trace mineralrequired in microgram quantities and an 
important cofactor in 25selenoproteins included in immune,endocrine 
systems.It is readily bioavailable as  an inorganic salt like  selenate 
.Depressed selenium level in humans is associated with decreased IgG 
&IgM.Mostly macrophages &neutrophils require the  selenodependent 
generation of ROS and decreased selenium causes a decrease in neutrophil 
 function.Th e reduced levels of selenium are inversely correlated with 
procalcitonin and CRP.Procalcitonin is a marker of inflammation and are 
produced by the thyroid gland and also the  neuroendocrine cells of 
intestine &lung.It is also a cofactor in thioredoxin reductase that are 
essential for protection against the free  radicals. 
GUT DIRECTED THERAPIES; 
The possibility that gut dysfunction or failure drives disease processes 
suggests that gut directed therapies to attenuate gut failure or preserve gut 
function may improve patient outcomes in day to day clinical practice. 
There are a number of methods by which at least in theory gut function 
might be modulated favourably these include:  
 Physical methods such as early post operative mobilisation  
 Drugs such as Prokinetics and avoidance of opiates  
 Immuno nutrients such as glutamine, arginine, fish oils, antioxidants and 
trace elements  
 Modulation of GI microflora by using synbiotics and selective gut 
decontamination.  
 Combination approaches.  
 
 
 Immunonutition 
  Defined as the addition of specific nutrients in greater than normal 
concentrations, to  modulate the immune function. It has been recently 
coined as pharmaconutrition.    It constitutes of ARGININE,  GLUTAMINE, 
FISH   oil. BCAA, NUCLEOTIDES, vitamins and minerals and can be 
administered enterally and parenterally. 
ORIGIN:  
Nutritional immunology  as a branch of science dates back   to 1810 
with the coincidence  of lymphoid  tissue atrophy and malnutrition. The 
discovery of vitamins in the early 1900s led to the contribution to immunity 
and other defenses. A hiatus in the progress of  immunonutrients  was noted 
during world war 2 and the resurgence of interest in  the 1960s.Attempts of 
enteral nutritional therapy is documented for more than 3500 years back to 
1500 BC,when the ancient Egyptians tied animal bladders to small clay or 
ceramic pipes to deliver medications and nutrients by rectal enemas. More 
than a millennium later in 400 BC greek physicians used apparatus to instill 
wine , whey, and barley, broth by rectum. 
Macronutrients: 
 Arginine: 
 It was  first discovered 100 years ago as a basic AA. 
 Naturally digested in diets at a rate of 3-5gm/day Most often found in 
meats and nuts. It is available as a denovo synthesis from citrulline and by 
protein breakdown. NO  acts as a signaling pathway for immune cells and 
other cells. 
PATHOPHYSIOLOGY FOLLOWING SURGERY 
The Immature cells of myeloid origin appear in the circulation and 
lymph, and the cells secrete the enzyme  arginase which further degrades  
arginine and leads to decreased T- lymphocyte function and producing 
decrease in CD4 cells and increase in IL-2and IFN-gamma. 
ARGININE  metabolism: 
The   Arginine  Denova synthesis from L-citrulline is performed by 
the enzyme arginosuccinate synthase and arginosuccinate lyase ,both the 
enzymes are rate limiting . Arginine is degraded by the enzymes arginase  to 
urea and ornithine. The biosynthesis of citrulline from L-ornithine depends 
on the enzyme OTC(ornithinecarbomoyl transferase).Arginine is degraded 
by the enzymes NOS to the biological active intermediate NO (endothelium 
derived factor).Nitric oxide is essential for GIT functions like bacteiostasis, 
increase in the immune defenses ,increases the mucus secretion, motility 
and splanchnic circulation. 
 
  
 
 
 Improves wound healing 
 Increases T Helpercells 
 Secretagogue for GH,PRL,insulin  
 Major metabolic fuel  for  enterocytes, colonocyte  &immune cells 
Collagen synthesis   
 
 GLUTAMINE: 
 Precursor of antioxidant glutathione  
 Most abundant free AA 
 Solubility of glutamine is low in aqueous state.  
 Fuel for rapidly dividing  cells. 
Maintains gut barrier function  Substrate for renal ammoniagenesis. It 
contributes to the  formation of mucin &  surface integrity of the intestinal 
epithelial cells .Increases the synthesis of heat shock proteins which are 
paramount for cellular recovery and protection of organ failure . Proves to 
be essential for the activation of the genes for heat shock proteins. 
POLYUNSATURATED FATTY ACID: 
The longchain omega -6 and omega-3 fattyacid compose the structure 
of cell membrane and stabilizes the cell and are the precursors of 
“eicosanoid and docosanoids” involved in the regulation of 
inflammation,immunity and platelet aggregation These include linoleic acid 
(omega -6) and alpha linolenic acid (omega 3). 
  
Omega 6&3 fatty acids cannot be synthesized in the body due to the carbons 
in the position 3 & 6.Arachinoid acid in the body is the major fatty acid 
content in the immune cell membrane and its predominant eicosanoids are 
PGE4 and LTB4. The membrane content of omega 3 FA is increased  and it 
causes a changed pattern of production of eicosanoids ,which have a marked 
beneficial impact on the inflammation and immunity mechanism.Saturated 
and trans fat produce an elevated TNF –alpha. Flesh of oily fish is abundant 
with EPA &DHA, the good sources of preformed omega 3FA. Cold water 
fish like sardines ,mackerel and tuna are the richest source of EPA &DHA. 
The  content of EPA &DHA varies according to the fish species. It is 
recommended to consume 2 portions of fish /week(one portion =140gm) 
and is found to have a protective effect on the cardiovascular and immune 
system. The Inuits of Greenland ingest a high fatty meal, inspite their 
 incidence of cardiovascular diseases are extremely minimal due to the 
purely fish based diet.  
 
Omega 3 FA are_ anti-inflammatory and  consists of  alpha linolenic acid, 
EPA and DHA.  Exception to this rule is Gamma linolenic acid is an  
“omega -6” but has an anti-inflammatory effect when administered 
exogenously. Omega 3 FA substitutes for the Arachidonic acid in the 
macrophages and neutrophil, and hence blunts the production of 
proinflammatory mediators. It competes for the cyclooxgenase and 
lipooxgenase and inhibits the production of Arachidonic acid metabolites. 
Resolvins and protectins are the byproducts of DOHA have shown to reduce 
cellular inflammation. The ideal ratio of omega 6:omega3 is 1:6 but modern 
 diets have as high as 20:1.The beneficial effects are demonstrated in 
conditions like crohns ,IGA nephropathy & atopic dermatitis .It has been 
noticed of proven benefit in critical care and cancer patients. 
 
VITAMINS: 
  “ A vitamin is a substance that makes you ill if you don’t eat it”- 
“ALBERT SZENT_GYORGYI NOBEL PRIZE IN PHYSIOLOGY 1937” . 
These organic compounds  are required in trace amounts in the diet and 
cannot be synthezised in organisms.It has diverse functions in the human 
system. 
 
VITAMIN A: 
  The immune system functions effectively with the required amounts 
of micronutrients in the diet. It is well known  and proved that vitamin A 
deficiency leads to suppression of  the immune mechanism and alters the 
innate, Tcell and antibody mediated responses  by the host cells. This  
enhances the susceptibility to infections as well as the morbidity. Later a 
 viscious cycle develops ,with the infections aggravating and reducing   the 
vitamin levels by decreasing the intake and elevated losses. The mechanism 
of Vitamin A action on both types of the immune system is by the 
transretinoic acid,and nuclear retinoic acid recptors. Vitamin A deficiency 
leads to alteration of ,the  integrity of mucosal epithelium and an enhanced 
capacity of the microbes to invade  the eye,respiratory tract &GIT. The  
deficiency in children are more prone to diarrhoeal &respiratory disease like 
measles. It is observed with decreased phagocytosis &oxidative burst 
capacity of the macrophages , and a decline of the  number & function of 
NK cells. Vitamin A supplementation antagonizes the  proinflammatory 
mediators like IL-12 &TNF alpha. Also observed is  the antibody mediated 
immunity  decline. In humans antibody titre to various vaccines has shown 
improvement with vitamin A addition. 
 
VITAMIN D: 
 The major role of the vitamin is  its regulation of calcium and bone 
metabolism and is proved beyond doubt that its active metabolite  1,25-
dihydroxycholecalciferol {vitamin D3} is  as a strong  immunoregulator.  
Majority of  cells of the immune family express vitamin D receptors except 
B cells. Active form of vitamin D behaves as a immune system 
 modulator ,reducing the  excess expression of inflammatory cytokines and 
increases the oxidative burst of macrophages. 
 
ZINC: 
Raulin discovered the metal and its function in 1869. He observed 
that zn was required for the growth of aspergillus niger.  Zinc deficiency 
was prevalent  in Iran and the Arabian counties due to the whole grain and 
cereal based diet. Extreme Zn deficiency manifested as Acrodermatitis 
enteropathica with features of hypogonadism , alopecia, 
hepatosplenomegaly, dwarfism, anaemia ,impaired wound healing and 
mental retardation. 
Humans contain 2-3 gm of zinc ,most of which is bound to proteins. 
The highest  tissue  content is found in the prostate, seminal fluid, uveal 
tissue and skin. More than 300 enzymes and 2000 transsignalling molecules 
contain the metal. Half of  the body store of zinc is in the bones. There is no 
storage depot available and hence continuous supply is mandatory for  
metabolic needs, growth and tissue repair. It is available in fish, meat, eggs 
oyster. Legumes and cereals only contain moderate amounts and 20-40% is 
absorbed. It is absorbed from the duodenum and proximal jejunum and 
 excreted in faeces. Absorption is hampered by the presence of  calcium, 
phytates , phosphates. Animal proteins and EDTA increase the absorption  
from the gut. Zn decrease the oxidative stress and inflammatory cytokines. 
NADPH oxidase are a group of  plasma membrane associated enzymes 
which catalyze the production of  O2- from O2 by utilizing NADPH as the 
electron donor. Zn is an inhibitor of this  enzyme. Zn is an essential 
component of Thymulin , a thymic hormone involved in  the maturation and 
differentiation of T cells. The  expression of IL-2 &IFN- gamma[Th1] are 
depleted in Zn deficiency.   
 
  
Zinc is a cofactor of catalytic, structural and regulatory proteins throughout 
the body ,especially immune system and wound healing. zinc deficiency can 
occur in high calorie PN and EN  and manifests as abnormal sense of smell 
& taste , skin rash, failure to thrive, delayed  wound healing and loss of hair. 
It is a vital cofactor to RNA &DNA polymerases and its deficiency leads to 
arrested cell cycle growths. Clinically deficiency manifests as decreased NK 
cell number and function and increased rate of infections. Within the 
intestine it has important antimicrobial roles of activatind the 
matrixmettaloproteinases which activates the antimicrobial defensins from 
 the intestinal paneth cells. It also has a structural role in the intestinal tight 
junction proteins, and holds the enterocytes and other epithelial cells. Zinc 
status is assessed by the serum concentration which is less than the 
intracellular concentration, normal serum Zn levelis 80-160microgm/l and 
less than 60 micro gm requires supplementation. Optimal zn dosing has not 
been determined, but recommended intakes are 2-5mg/dy in PN & 11-
19mgday in EN. 
POSTOPERATIVE COMPLICATIONS: 
SEROMA:  
They are the  complications after a operative procedure and are 
attributed when large skin flaps are constructed  like in axillary dissection , 
mastectomy and large ventral hernias with polypropylene mesh. Prevention 
of seromais by the placement of drains and like in other wound infections is 
opening of the sutures and healing by secondary intention. 
Surgical site infection: 
The incidence of SSI  accounts to almost 40% of nosocomially 
acquired infections among surgical patients. The burden of  infections leads 
to morbidity and increased healthcare costs. The surgical wound includes  
both  the external and internal areas that involves the entire operative site. 
Wounds are divided into three  categories 1) superficial, which includes the 
 skin and subcutaneous tissues 2)Deep, includes the fascia and muscles 
3)Organ space, the internal organs of the body if the operation includes that 
area. The criteria for diagnosis is proposed by the CDC –superficial 
incisional-infection less than 30 days after surgery involves skin and 
superficial tissue plus one of he following purulent drainage, symptoms of 
erythema, pain and local edema and diagnosis by a surgeon. Deep 
incisional-less than 30 days after surgery with no implant and soft tissue 
involvement plus  one of the features purulent drainage from the deep space  
but no extension into the organ ,abscesses found on direct ,radiologic 
examination or on reoperation and symptom of wound dehiscence. Oragan 
space is –infection <30 days with no implant and one of the following 
purulent drainage from the drain and cultured organisms from the organ 
space. SSI develop due to the contamination with micro organisms  and the 
source is the inhabitant flora from skin and bowel. The source is exogenous 
if there is a break in the sterile technique. The microbiology varies with the 
types of procedures. Most of them are gram positive bacteria, staph aureus 
is the most common, coagulase negative staph and enterococcus spp. In Gi 
surgeries gram negative bacilli is the predominant species like E.coli, 
pseudomonas and enterobacter. Most SSi presents  in the 5th and 6th POD. 
80% of the infections occur within 30 days after the surgery. Both 
 superficial and deep SSIs are associated with erythema , redness, edema and 
drainage. The wound is often soft or fluctuant at the site. 
CLASSIFICATION OF SURGICAL WOUNDS:  
 
The risk factors for postoperative wound infection are age, 
obesity ,diabetes emergency procedure, drains, inadequate antibiotic 
coverage ,preoperative hospitalization ,type of operation and prolonged 
operation ,malnutrition in the patient preoperatively, Inadequate skin 
antisepsis and defective sterilization. The administration of antibiotic one 
hour before the surgical incision is crucial to attain adequate tissue 
therapeutic levels. The intra-operative asepsis is a predominant factor  in 
decreasing  the postoperative wound infection. All operative personnel must 
ensure proper hand hygiene as a team. The proper skin preparation with a 
 antiseptic solution is essential  along with the a careful sterile drape.The 
intraoperative  surgical techniques to be followed are 1)careful tissue 
handling techniques , 2)precise dissection, hemostasis and  thorough 
debridement of unhealthy tissues 3)avoidance  of spillage  of the 
intraluminal contents 4)maintenance of blood supply of the operated organ 
5)elimination of foreign body 6)patient is kept in a euthermic state  and 
hydrated 6)Irrigation of pus in the wound with normal saline. Treatment 
includes removal of the sutures and drainage and thorough wound washing 
with normal saline and for culture and sensitivity, meanwhile to start on 
empirical antibiotic therapy. If the deep fascia is involved and burst 
abdomen has ensued  a reoperation is mandated. 
 
Anastomotic leaks: 
 It is  the most dreaded  complication following Colorectal surgery.It 
is reported to 3-26%. Numerous conditions are associated with an elevared 
risk of leak. Mechanical bowel preparation  results in structural alterations 
to the colonic mucosa and inflammatory changes in the bowel wall. The 
rationale of MBP prior to elective  GI surgeries is debated due to the  
increased anastomotic leaks ,wound infections and resurgeries. The level of 
the anastomosis in the GI tract is  of prime consideration as the ileocolic, 
ileorectal and small bowel are less prone  compared to 
 esophageal ,.colorectal and pancreaticoenteral .In the esophagus the lack of 
serosa is a contributing factor ,the texturity of the pancreatic gland  and the 
size of the pancreatic duct, the surgeon experience  plays a major 
role.Intraluminal distension leads to the dehiscence  of anastomosis. The 
Mechanical strength of the anastomosis is critical in the nascent period and 
is dependent on the sutures and staplers,  as well as on the endothelial cells 
and fibronectin complex. The most fundamental bowel suturing technique is 
to ensure  a watertight and airtight anstomosis. Intraabdominal drains if left 
for more than 24-48 hours predispose to infection. Defunctioning stomas 
does not contribute to the  decrease  in leak rate but reduces the  
perianastomotic complication. The clinical features suggestive of leak are 
fever ,tachycardia, peritonitis, fistula to skin, oliguria  and abdominal 
distension. The clinical features are the result of loss of integrity of the 
anastomosis and seepage of  intestinal contents. The leakage can be either 
diffuse involving the peritoneal cavity (uncontrolled leak) or shelled off by 
omentum ,abdominal wall and the contigous  of bowel.If a surgical drain is 
placed it leads to an enterocutaneous fistula. The imaging modality of 
choice is water soluble contrast either oral ,IV or rectal contrast but now is 
supplanted by The clinical features suggestive of leak are fever ,tachycardia, 
peritonitis, fistula to skin, oliguria  and abdominal distension. The imaging 
modality of choice is water soluble contrast either oral ,IV or rectal contrast 
 but now is supplanted by CT. Leaks are most common in 5-7 th POD. The 
leak rate is highest if the anastomotic site is 7cm from the anal verge. 
Definition of anastomotic leaks: 
 faecal fistula to skin 
 fever >38 or septicaemia 
 radiological signs of AL 
 Intraperitoneal abscess or peritonitis 
Principles of good and reliable anastomosis 
 Excellent exposure and access to large bowel 
  To ensure blood supply of the anastomosed stumps 
 Prevention of sepsis or  faecal contamination 
 Suture or staplers are properly placed and confident of good 
approximation of all layers of the bowel(most important is the 
submucosa) 
  To aim for tension free anastomosis “splenic flexure is  released” 
  distal obstruction is prevented 
The surgical principles are to achieve a good vascularity and the are 
sutures must not be placed too tight or too deep and the bowel clamps 
should not include the mesentry. Submucosa is the strongest layer of the 
bowel wall  and hence single layer technique is supported  and 
 extramucosal interrupted sutures is the procedure of choice. Theoritically 
two layer anastomosis produces more tissue necrosis ,ischaemia and 
narrowing of the bowel lumen. The serosa of the small bowel should not 
be stipped of its mesentry for more than 3-4 cm. The marginal artery of 
colon and the last vascular arcade of the small bowel is left intact. 
 UTI: 
It is a common postoperative event  and a major predisposing factor is 
the presence of urinary catheter and the risk increases manifold with 
increased duration  of catheterization {>2days}. E.coli is the most common 
source of infection with short term catheterization. High fever that occurs 
after 5-8days is more worrisome than early preoperative fever.In the first 
48-72 hours of abdominal surgery,  atelectasis is an important cause of fever. 
PNEUMONIA: 
It is diagnosed by the presence of fever, leucocytosis and purulent 
sputum production and an infiltrate on CXR.Pneumonias in postoperative 
patients are treated as nosocomial. Patients requiring more than 48 hours of 
ventilation are more prone. 
 
 
 Enhanced Recovery After Surgery : 
 
 
The enhanced recovery after surgery programmes are the standard of 
care  in elective surgical settings all over the world. It has also been 
advocated that the earliest  return of bowel function  is the benefit about the 
package by curtailing postoperative ileus, nausea and vomiting .The current 
preoperative fasting  guideline mentions  that a 2 hours of fasting period for 
clear fluids and   a light meal is 6 hours .The prolonged preoperative fasting 
was advocated to prevent pulmonary aspiration but on the contrary it causes 
hyperglycaemia  and increased stress response. They are in a more anabolic 
state and have less postoperative nitrogen and protein loss. The  mechanical 
 bowel preparation leads to dehydration ,fluid &electrolyte disturbances 
especially in the old age  and is not proved beneficial .It increases the  risk 
of anastomotic leak and prolongs the  postoperative ileus. Prophylaxis 
against thromboembolism is advocated with LMW heparin or 
unfractionated heparin. Prophlactic antibiotics is administered one hour 
prior to skin incision and is effective against both aerobes and anaerobes .A 
single dose is as effective as a multidose regimens but further  doses should 
be given in prolonged cases >3 hours. The optimal combination of 
antibiotics is not established ,but a second generation cephalosporin and 
metronidazole are suggested. Postoperative nausea and vomiting by patient 
experience suggests are more stressful than pain. Risk factors are females, 
smoking and with a history of motion sickness. Surgical incisions-transverse 
or curved incisions cause less pain & pulmonary dysfunction than vertical 
incision.laparoscopic surgeries facilitate early recovery. Nasogastric tubes 
delay the recovery of bowel function. 
JOURNAL REVIEW: 
All these studies conducted worlwide are with preoperative 
immunonutrients in various GI surgeries and the results are variable due to 
the heterogenous populations . 
  A study of preoperative oral IMN supplements in esophageal cancer 
patients –published in the journal of nutrition and health april 2014 
vol 18 issue 4  pg 437-440.result shows a improved outcome. 
 A study of 50 patients of colorectal carcinoma conducted in italy  
2002 by BRAGA 
 Gianotti of italy in 2002 studied 102 GI carcinoma patients 
 Heril of japan in 2006  on colorectal ca patients .study population was 
33. 
 Gunerhan of turkey 2009 on 13 GI tumours patients. 
 Mikagi of japan 2011  on 13 hepatocellular ca patients planned for 
liver resections  ,the study was underarmed  and reported 
improvement in the biochemical parameters. 
 Fugitani of japan 2012 on 120 GI carcinoma patients 
 Barker of Australia 2013  with a study population of 46 
 Aida of Japan 2014 on whipples procedure of 25 patients. 
PROUD STUDY-Is a RCT conducted by the germans  to evaluate the 
effect of  longterm preop IMN on liver transplantion patients  and is in 
progress. 
 STUDY DESIGN:  
Case Control study 
SETTING: 
Department of surgery and surgical gastroenterology  at Stanley 
medical college, Chennai. 
ETHICAL APPROVAL: 
The study was approved by the Institutional committee in January 
2015. 
Inclusion criteria: 
All  patients  above 13years of age. 
Planned for elective major Gastro intestinal surgery 
 
Exclusion Criteria : 
 Intestinal obstruction. 
 Vomiting and diarrhea. 
 Diabetes mellitus. 
 Pregnancy 
 No evidence of liver and renal disease 
 
 
 Materials and  Methodology: 
 
A prospective non randomnized study which included 50 patients 
who underwent major elective GI surgery for both benign and malignant 
diseases with IMN supplementation. The study group n=50 where 
administered 30 gms of IMN formula three times a day for 5 days 
preoperatively by oral route.The control group were given a normal diet 
during the study period.The preoperative variables measured were 
weight,BMI.The post operative variables are the primary outcomes of 
infectious complications such as SSI,UTI,pneumonia ,wound abscess and 
anastomotic leaks were recorded in the prescribed proforma. 
 
 
 
 
 
 
 
 
 
 
 COMPOSITION OF IMMUNONUTRIENTS 
 
 
 
 
 
Nutrients 
 
Units Per/100gm 
powder 
    
Energy   Kcal  337.4 
protein    gm  20 
 carbohydrate   gm  63 
 fat    gm  0.6 
 L-glutamine   Mg  500 
 l-arginine   Mg  3000 
 DHA   Mg  80 
 Linoleic acid   Mg  32 
 taurine   Mg  38 
 colostrum   Mg  2 
 vitamin C   Mg  83 
 vitaminE    Mg  33.3 
 vitamin K   Mg  50 
 vit A   Mcg  1812 
 biotin   Mcg  30 
 vit D   Mcg  2.2 
 Essential minerals        
 Iron   Mg  18 
 Zinc   Mg  11 
 Selenium   Mg  15 
 Magnesium   Mcg  200 
 Calcium   Mg  1200 
 Copper   Mcg  410 
 molybdenum &chromium  Mcg  35 
 phosphorus-   Mg  700 
      
 RESULTS & OBSERVATIONS 
The age of the persons varies from 40 to 80 years. The age wise, sex 
wise distribution  are appended in the diagram 
 
Agewise sexwise  distribution case group  
 
 
The male persons are comparatively higher in number both  in  case groups 
and control groups as illustrated by the  pie diagram below. 
 
 
 
 
  
 
 
 
 
Sexwise case group 
 
 
 
Surgeries are done  as illustrated in the chart below according to the clinical 
diagnosis made earlier. 
 
There were 11 types of  surgeries done on 50persons of  case  group- the 
details of which are  appended below. 
 Details of surgery   
GJ+JJ 
8 
extcholecystectomy 
1 
Rt hemicolectomy 
10 
Lt hemicolectomy 
10 
APR 
5 
CBD Exploration 
5 
Cholecystectomy   
5 
Ltd resection 
 +anastomosis 
1 
Revision  closure 
3 
resection 
anastomosis 
1 
Hartman 
Procedure 
1 
Total 
50 
 
 
The detailed surgeries done are best illustrated  by the diagram also for easy  
visibility. 
 
 
 
Types of surgeries done 1 
 
  
A similar number of surgeries were done on the control group of fifty 
persons  alsoto monitor  the effect of the intervention of nutrition  on the 
case group. 
 
 
The impact of nutrients  
The  data collected on the 50 patients of case group on parameters of 
weight and BMI are appended below- before  and after the intervention of 
added immuno nutrition by oral intake. 
Before operation –Case  Group                   After surgery and  
  intervention of nutrition 
 Patients       weight(avg)      BMI(avg)          weight(avg)      BMI(avg)     
Female          53.92kgs               21.69             56.54              22.9 
Male             61.3 kgs                 21.94            61.78              22.09 
Total             59.4 kgs                 21.88           60.42               22.3 
  
Group Statistics
50 1.6470 .07702 .01089
50 1.6442 .06737 .00953
50 59.40 5.901 .834
50 60.42 5.296 .749
50 21.8776 1.46839 .20766
50 22.3704 1.82726 .25841
50 1.6470 .07702 .01089
50 1.6442 .06737 .00953
50 60.42 5.296 .749
50 59.50 4.925 .696
50 22.30305 1.746991 .247062
50 22.03404 1.732114 .244958
Group
Case
Control
Case
Control
Case
Control
Case
Control
Case
Control
Case
Control
Hieght - Preop
Weight - Preop
BMI - Preop
Height - Postop
Weight - Postop
BMI - Postop
N Mean Std. Deviation
Std. Error
Mean
 
 
 
 Others .UTI 
 
There was an isolated incidence in the Case group with nutrients intake and it 
is  only two with this symptom in the control group. hence there is no 
significant variance between the groups. 
Pneumonia 
Considering the attack of pneumonia only.. 5 patients got suffered in the case 
group whereas this is  as high as 36 % in the standard group.  The p <0.05  is 
significant  . The     P value is 0.001 
Chi-Square Tests
10.767b 1 .001
9.237 1 .002
11.498 1 .001
.001 .001
10.658 1 .001
98
Pearson Chi-Square
Continuity Correction a
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 10.
78.
b. 
 
Wound infection 
      The case group was affected by 36% and the control  group by an 
enhanced level 50%. It can be confidently assessed that immunonutruients  has 
a significant impact  on  the patients in reducing factors which help to increase 
the symptom of wound infection.            
-  
 Crosstab
15 24 39
31.3% 48.0% 39.8%
33 26 59
68.8% 52.0% 60.2%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
Wound infection
- Day 3
Total
Case Control
Group
Total
 
 
Abd abcess 
Both the groups have registered a totally negative incidences during the study 
period making it irrelevant to comment on comparision. 
Anastomotic Leak 
The control group  with absence of added nutrients  intervention reported a 
occurance of one patient while it is none on the case group. 
Others 
The control  group had a single instance  complication. 
Length of stay 
The average hospital stay of the case group was 14.82 days while that of 
control group was  higher at 16.78 days, indicating a reduction of 12% on 
hospital stay . The  lower number of hospital stay along with better quality  of 
life at hospital undoubtedly  help to conclude that the intervention with 
 immunonutrients on patients has a positive impact on healing. 
The above said point are best illustrated by the table and the bar diagram 
shown below. 
Post operative complications 
Symptoms Cases Controls 
UTI 1 2 
Pneumonia 5 18 
Wound infection 18 25 
Abd abcess - - 
Anastomotic leak - 1 
Avg Los 14.82 16.17 
 
 
 
 
 It  is evident from the above data that after the intake of 
immunonutrients  the weight of all  categories  of the sample group  has 
marginally increased inspite of  the cxpected correction on the lower side.  
DISCUSSION: 
Multiple studies  and clinical research have demonstrated improved 
patient outcomes  and reduced length of stay  particularly in the elective GI  
surgery cases. The wound infections have marginally decreased in the study 
group  compared to the control group(18vs25) and the incidence of 
pneumonia is elevated in the control group. The patients tolerated the 
Immunoenriched formula due to its palatability.One patient severely 
malnourished following an enterocutaneous fistula  had benefitted 
remarkably and had no complications following revision ileostomy 
closure.The consensus view from multiple RCT and metaanalysis supports 
perioperative nutritional support in elective GI surgery patients.Daly et al 
has conducted two studies in 1992 &1995 with surgical patients as study 
population  and demonstrated decreased wound infections and hospital 
stay.Braga et al in 1998 conducted in surgical patients n=110 and 
demonstrated decreased length of stay and also infectious complications. 
“XU et al 2006” with 60 patients on preoperative IMN had fewer 
postoperative complications 7%vs26%.LOS is <3 days.A study of 
 perioperative IMN in Elective GI surgery patients was conducted at  Stanley 
Surgical gastroenterology  unit  by S.K perumal et al    with 50 patients and 
the observed results are there was  no difference in the postoperative 
infections but proved to be of benefit in malnourished group.Hence the 
study has similarity with the malnutrition component.The different 
composition of the IMN formulas available commercially and utilized in the 
numerous studies worlwide ,makes it difficult to comprehend the exact 
requirements in terms of dosage and  route of administration which is 
beneficial in the recovery of the surgery patients.Although studies indicate 
that the amount of arginine required is >12 gm/1000 calories,glutamine 10to 
30gm/day ,omega 3FA 1-4 gm/day for its beneficial outcome. 
CONCLUSION: 
 The study outcome has proved a beneficial reduction of  infectious 
complications  and  substantial improvement  with the immunonutrient 
formula  and it emphazies  the subset of malnourised patients are markedly 
benefitted . 
LIMITATIONS: 
The limitation of the study is that  biochemical  markers like serum 
prealbumin and serum transthyretin the markers of  the nutrional protein 
status was not measured .The more specific  inflammatory markers   
 CRP,IL-6, TNF-alpha ,neopterin  were not recorded in the postoperative 
setting and hence the biochemical variables of inflammation could not be 
extrapolated with the positive improvement in clinical outcome with respect 
to infections. 
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 Pre Operative Proforma 
1. Name : 
2. Age / Sex : 
3. History : 
4. General Examination : 
5. Systemic Examination : 
6. Clinical diagnosis : 
7. Comorbid illness : 
8. Planned surgical procedure : 
9. Weight and BMI : 
Weight BMI 
  
10. Biochemical investigations: 
hb      TC DC LT RFT 
     
 
ORAL IMN FORMULA : 
Day 1 2 3 4 5 
     
 
 
 
 Pre Operative Proforma 
Surgical procedure done : 
Weight and BMI : 
            POD  DAY  
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UTI 
       Pneumonia 
Wound inf 
 Abd 
           abscess 
Anastomotic 
leak 
Ooo1Other 
Los 
 T-Test 
 
[DataSet1] D:\2015\DATA.AUG-SEP.2015\Dr.Jayalakshmi.mmc.sav 
 
Group Statistics
50 60.44 4.949 .700
50 61.30 4.464 .631
Group
Case
Control
Age
N Mean Std. Deviation
Std. Error
Mean
 
 
Independent Samples Test
.051 .821 -.912 98 .364 -.860 .943 -2.731 1.011
-.912 96.975 .364 -.860 .943 -2.731 1.011
Equal variances
assumed
Equal variances
not assumed
Age
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
 
Crosstabs 
 
[DataSet1] D:\2015\DATA.AUG-SEP.2015\Dr.Jayalakshmi.mmc.sav 
 
Sex * Group 
 
Crosstab
38 37 75
76.0% 74.0% 75.0%
12 13 25
24.0% 26.0% 25.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Male
Female
Sex
Total
Case Control
Group
Total
 
 
 Chi-Square Tests
.053b 1 .817
.000 1 1.000
.053 1 .817
1.000 .500
.053 1 .818
100
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 12.
50.
b. 
 
 
Clinical Diagnosis * Group 
 
Crosstab
20 20 40
40.0% 40.0% 40.0%
5 5 10
10.0% 10.0% 10.0%
8 8 16
16.0% 16.0% 16.0%
5 5 10
10.0% 10.0% 10.0%
5 5 10
10.0% 10.0% 10.0%
1 1 2
2.0% 2.0% 2.0%
3 3 6
6.0% 6.0% 6.0%
2 2 4
4.0% 4.0% 4.0%
1 1 2
2.0% 2.0% 2.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Ca ascend
ca rectum
Ca stomach
CB Calculi
CBD Stone
GB Cancer
Loop ielost
Sigmoid
TB ileocaec
Clinical
Diagnosis
Total
Case Control
Group
Total
 
 
 Chi-Square Tests
.000a 8 1.000
.000 8 1.000
100
Pearson Chi-Square
Likelihood Ratio
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (44.4%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
 
Plannedsurgeical Procedure * Group 
 
Crosstab
5 5 10
10.0% 10.0% 10.0%
5 5 10
10.0% 10.0% 10.0%
5 5 10
10.0% 10.0% 10.0%
1 1 2
2.0% 2.0% 2.0%
8 8 16
16.0% 16.0% 16.0%
1 1 2
2.0% 2.0% 2.0%
1 1 2
2.0% 2.0% 2.0%
10 10 20
20.0% 20.0% 20.0%
1 1 2
2.0% 2.0% 2.0%
2 2 4
4.0% 4.0% 4.0%
1 1 2
2.0% 2.0% 2.0%
10 10 20
20.0% 20.0% 20.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
APR
CBD Exploration
Cholecystectomy
extcholecystectomy
Gastrecto CJ+JJ
Hartman procedure
Limited resction
Lthemicol ectomy
Resection anastomo
Revision closure
Revision Closure
Rthemicol ectomy
Plannedsurgeical
Procedure
Total
Case Control
Group
Total
 
 
 Chi-Square Tests
.000a 11 1.000
.000 11 1.000
100
Pearson Chi-Square
Likelihood Ratio
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (50.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
 
Surgical Procedure done * Group 
 
Crosstab
5 5 10
10.0% 10.0% 10.0%
5 5 10
10.0% 10.0% 10.0%
5 5 10
10.0% 10.0% 10.0%
1 1 2
2.0% 2.0% 2.0%
8 8 16
16.0% 16.0% 16.0%
1 1 2
2.0% 2.0% 2.0%
1 0 1
2.0% .0% 1.0%
0 1 1
.0% 2.0% 1.0%
10 10 20
20.0% 20.0% 20.0%
1 1 2
2.0% 2.0% 2.0%
2 2 4
4.0% 4.0% 4.0%
1 1 2
2.0% 2.0% 2.0%
10 10 20
20.0% 20.0% 20.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
APR
CBD Exploration
Cholecystectomy
extcholecystectomy
Gastrecto CJ+JJ
Hartman procedure
Limited resction
Limited resection
Lthemicol ectomy
Resection anastomo
Revision closure
Revision Closure
Rthemicol ectomy
Surgical
Procedure
done
Total
Case Control
Group
Total
 
 
 Chi-Square Tests
2.000a 12 .999
2.773 12 .997
100
Pearson Chi-Square
Likelihood Ratio
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
14 cells (53.8%) have expected count less than 5. The
minimum expected count is .50.
a. 
 
 
UTI - Day 3 * Group 
 
Crosstab
1 2 3
2.1% 4.0% 3.1%
47 48 95
97.9% 96.0% 96.9%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
UTI - Day
3
Total
Case Control
Group
Total
 
 
Chi-Square Tests
.303b 1 .582
.000 1 1.000
.310 1 .578
1.000 .515
.300 1 .584
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.
47.
b. 
 
 
Pneumonia - Day 3 * Group 
 
 Crosstab
4 18 22
8.3% 36.0% 22.4%
44 32 76
91.7% 64.0% 77.6%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
Pneumonia
- Day 3
Total
Case Control
Group
Total
 
 
Chi-Square Tests
10.767b 1 .001
9.237 1 .002
11.498 1 .001
.001 .001
10.658 1 .001
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 10.
78.
b. 
 
 
Wound infection - Day 3 * Group 
 
Crosstab
15 24 39
31.3% 48.0% 39.8%
33 26 59
68.8% 52.0% 60.2%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
Wound infection
- Day 3
Total
Case Control
Group
Total
 
 
 Chi-Square Tests
2.868b 1 .090
2.211 1 .137
2.887 1 .089
.103 .068
2.839 1 .092
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 19.
10.
b. 
 
 
Abd  abscess  - Day 3 * Group 
 
Crosstab
48 50 98
100.0% 100.0% 100.0%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
NoAbd  abscess  - Day 3
Total
Case Control
Group
Total
 
 
Chi-Square Tests
.a
98
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because
Abd  abscess  - Day 3 is a constant.
a. 
 
 
Anastomotic Leak - Day 3 * Group 
 
Crosstab
48 49 97
100.0% 98.0% 99.0%
0 1 1
.0% 2.0% 1.0%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
No
4
Anastomotic
Leak - Day 3
Total
Case Control
Group
Total
 
  
Chi-Square Tests
.970b 1 .325
.000 1 1.000
1.356 1 .244
1.000 .510
.960 1 .327
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
49.
b. 
 
 
Others - Day 3 * Group 
 
Crosstab
0 1 1
.0% 2.0% 1.0%
48 49 97
100.0% 98.0% 99.0%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
Others
- Day 3
Total
Case Control
Group
Total
 
 
Chi-Square Tests
.970b 1 .325
.000 1 1.000
1.356 1 .244
1.000 .510
.960 1 .327
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
49.
b. 
 
 
UTI - Day 7 * Group 
 
 Crosstab
1 2 3
2.1% 4.0% 3.1%
47 48 95
97.9% 96.0% 96.9%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
UTI - Day
7
Total
Case Control
Group
Total
 
 
Chi-Square Tests
.303b 1 .582
.000 1 1.000
.310 1 .578
1.000 .515
.300 1 .584
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is 1.
47.
b. 
 
 
Pneumonia - Day 7 * Group 
 
Crosstab
3 18 21
6.3% 36.0% 21.4%
45 32 77
93.8% 64.0% 78.6%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
Pneumonia
- Day 7
Total
Case Control
Group
Total
 
 
 Chi-Square Tests
12.874b 1 .000
11.167 1 .001
14.052 1 .000
.000 .000
12.742 1 .000
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 10.
29.
b. 
 
 
Wound infection - Day 7 * Group 
 
Crosstab
15 24 39
31.3% 48.0% 39.8%
33 26 59
68.8% 52.0% 60.2%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
Wound infection
- Day 7
Total
Case Control
Group
Total
 
 
Chi-Square Tests
2.868b 1 .090
2.211 1 .137
2.887 1 .089
.103 .068
2.839 1 .092
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 19.
10.
b. 
 
 
Abd  abscess  - Day 7 * Group 
 
 Crosstab
48 50 98
100.0% 100.0% 100.0%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
NoAbd  abscess  - Day 7
Total
Case Control
Group
Total
 
 
Chi-Square Tests
.a
98
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because
Abd  abscess  - Day 7 is a constant.
a. 
 
 
Anastomotic Leak - Day 7 * Group 
 
Crosstab
48 49 97
100.0% 98.0% 99.0%
0 1 1
.0% 2.0% 1.0%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
No
4
Anastomotic
Leak - Day 7
Total
Case Control
Group
Total
 
 
Chi-Square Tests
.970b 1 .325
.000 1 1.000
1.356 1 .244
1.000 .510
.960 1 .327
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
49.
b. 
 
 
Others - Day 7 * Group 
  
Crosstab
0 1 1
.0% 2.0% 1.0%
48 49 97
100.0% 98.0% 99.0%
48 50 98
100.0% 100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Yes
No
Others
- Day 7
Total
Case Control
Group
Total
 
 
Chi-Square Tests
.970b 1 .325
.000 1 1.000
1.356 1 .244
1.000 .510
.960 1 .327
98
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is .
49.
b. 
 
 
T-Test 
 
[DataSet1] D:\2015\DATA.AUG-SEP.2015\Dr.Jayalakshmi.mmc.sav 
 
Group Statistics
50 1.6470 .07702 .01089
50 1.6442 .06737 .00953
50 59.40 5.901 .834
50 60.42 5.296 .749
50 21.8776 1.46839 .20766
50 22.3704 1.82726 .25841
50 1.6470 .07702 .01089
50 1.6442 .06737 .00953
50 60.42 5.296 .749
50 59.50 4.925 .696
50 22.30305 1.746991 .247062
50 22.03404 1.732114 .244958
Group
Case
Control
Case
Control
Case
Control
Case
Control
Case
Control
Case
Control
Hieght - Preop
Weight - Preop
BMI - Preop
Height - Postop
Weight - Postop
BMI - Postop
N Mean Std. Deviation
Std. Error
Mean
 
  
Independent Samples Test
.289 .592 .193 98 .847 .00280 .01447 -.02592 .03152
.193 96.297 .847 .00280 .01447 -.02592 .03152
.036 .851 -.910 98 .365 -1.020 1.121 -3.245 1.205
-.910 96.876 .365 -1.020 1.121 -3.245 1.205
.956 .331 -1.486 98 .140 -.49279 .33151 -1.15067 .16508
-1.486 93.661 .141 -.49279 .33151 -1.15105 .16547
.289 .592 .193 98 .847 .00280 .01447 -.02592 .03152
.193 96.297 .847 .00280 .01447 -.02592 .03152
.162 .688 .900 98 .371 .920 1.023 -1.110 2.950
.900 97.488 .371 .920 1.023 -1.110 2.950
.000 .988 .773 98 .441 .269009 .347914 -.421415 .959432
.773 97.993 .441 .269009 .347914 -.421415 .959433
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Hieght - Preop
Weight - Preop
BMI - Preop
Height - Postop
Weight - Postop
BMI - Postop
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
 
 
T-Test 
 
[DataSet1] D:\2015\DATA.AUG-SEP.2015\Dr.Jayalakshmi.mmc.sav 
 
Group Statistics
48 15.15 3.690 .533
50 16.78 4.349 .615
Group
Case
Control
LOS
N Mean Std. Deviation
Std. Error
Mean
 
 
Independent Samples Test
1.908 .170 -2.002 96 .048 -1.634 .816 -3.254 -.014
-2.009 94.592 .047 -1.634 .814 -3.249 -.019
Equal variances
assumed
Equal variances
not assumed
LOS
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
 
 
 
 
